Last update: Jan. 16, 2021


Low Risk for breastfeeding

Moderately safe. Probably compatible.
Mild risk possible. Follow up recommended.
Read the Comment.

Sulfonylurea that stimulates endogenous insulin secretion. May cause hypoglycemia.
Indicated in the treatment of type 2 diabetes.
Oral administration, one daily dose

We did not find published data regarding the excretion of this substance through breast milk at the time this last update was completed.

The manufacturer (AEMPS 2o18, Sanofi 2016) and some authors do not consider it safe in lactation based on a publication of excessive passage to milk in animals (Hale, Serrano 2015)

Until there is further published data on this drug in relation to breastfeeding, known safer alternatives may be preferable, especially during the neonatal period and in cases of prematurity.

Diet, exercise, and breastfeeding improve blood sugar levels.

See below the information of this related product:


Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.

Other names

グリメピリド is Glimepiride in Japanese.

Is written in other languages:


グリメピリド belongs to this group or family:


Main tradenames from several countries containing グリメピリド in its composition:


Variable Value Unit
Oral Bioavail. 100 %
Molecular weight 490 daltons
Protein Binding 100 %
VD 0,12 l/Kg
pKa 4,32 -
Tmax 2 - 3 hours
T1/2 5 - 9 hours


  1. AEMPS. Glimepirida. Ficha técnica. 2018 Full text (in our servers)
  2. Sanofi-Aventis. Glimepiride. Drug Summary. 2016 Full text (in our servers)
  3. Serrano Aguayo P, García de Quirós Muñoz JM, Bretón Lesmes I, Cózar León MV. Tratamiento de enfermedades endocrinológicas durante la lactancia. [Endocrinologic diseases management during breastfeeding.] Med Clin (Barc). 2015 Jan 20;144(2):73-9. Abstract

Total visits


Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write to us at

e-lactancia is a resource recommended by El Parto Es Nuestro from Spain

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM